Global Cardioverter Defibrillator Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2023

Date : Nov 2019

|

Report ID : 55

|

Category : Healthcare

|
Report Format:  PDF EXCEL PPT WORD

Global Cardioverter Defibrillator Market was valued at US$ 8.2 billion in the year 2018 and is expected to reach US$ 10.67 billion by the year 2023, growing at a CAGR of 5.4%. A cardioverter defibrillator is either an implantable or external device that is used for the purpose of defibrillation, pacing of the heart or cardioversion. The device is used by patients who are at a high risk of death due to sudden cardiac arrest. The device checks the rhythm of the heart and when it senses abnormal beating, it sends electrical shock to restore the normal beating of the heart.

According to the World Health Organization, cardiac diseases are the number one cause of death globally. Approximately, 17.9 million people die due to cardiovascular diseases every year across the globe, which accounts for approximately 31% of deaths globally.

The major factors to drive the growth of the cardioverter defibrillator market are the increasing prevalence of cardiovascular diseases and the rising geriatric population. Changing lifestyles have led to increased smoking and alcohol consumption, and increasing obesity, which are some of the major risk factors associated with cardiac diseases. Additionally, technological advancements in cardioverter defibrillators will further drive the market.

The global Cardioverter Defibrillators Market is driven by increasing demand due to supportive legislation policies given by the government in developed countries. The innovation in implantable devices, as well as external defibrillators, is rising the demand for the Cardioverter Defibrillators Market. There is a rise in the innovation of implantable devices that includes products such as subcutaneous and transvenous patches mainly aim to increase the comfort level of the patient. The rise in the prevalence of non-communicable diseases is due to changing lifestyles. Cardiovascular diseases are a major segment of these non-communicable diseases. An increase in investments from private players helps the market to grow. 

However, these devices face stricter regulations compared to other categories of devices. The approval process usually takes more time which impedes the growth of the market. There is no awareness among people about taking corrective actions regarding cardiac arrest, which also hampers the growth of the market. Lack of skilled professionals to operate about defibrillator safety among different population groups may hamper the growth of the market.

However, the high cost of implantable cardioverter defibrillators may impede Cardioverter Defibrillator Market growth.

The Cardioverter defibrillators market report covers an in-depth analysis of the market including statistical and subjective data points, along with the key market drivers and opportunities & restraints that have positive or negative effects on the overall global market. An exclusive coverage is provided for market drivers and challenges & opportunities for a country-level market in the respective regional segments. The report comprises a competitive analysis of the key players functioning in the market and covers in-depth data related to the competitive landscape of the market and the recent strategies & products that will assist or affect the market in the near future.

Global Cardioverter Defibrillator Market, Segmentation Scope

By Product Type

Implantable Cardioverter Defibrillator (ICD)

  • Transvenous Implantable Cardioverter Defibrillator (T-ICD)
    • Single Chamber
    • Dual Chamber
    • Cardiac Resynchronization Therapy (CRT-D)
  • Subcutaneous Implantable Cardioverter defibrillator (S-ICD)

External Cardioverter Defibrillator

  • Automated External Defibrillator (AED)
  • Manual External Defibrillator
  • Wearable Cardioverter Defibrillator (WCDs)

By End User:

  • Hospitals
  • Public Access Market
  • Home Care
  • Others

According to the product type, the market is categorized into Implantable Cardioverter Defibrillator (ICD) & External cardioverter defibrillator. Further, ICDs are classified into Transvenous Implantable Cardioverter Defibrillator (T-ICD), Subcutaneous Implantable Cardioverter defibrillator (S-ICD). T-ICDs are further segmented in Single Chamber, Dual Chamber, and Cardiac Resynchronization Therapy (CRT-D). The External defibrillator is segmented into Automated External Defibrillator (AED), Manual External Defibrillator, and Wearable Cardioverter Defibrillator (WCDs).

Based on product type and end-user, the market is segmented into Implantable Convertible Defibrillators (ICD) and external Defibrillators. Hospitals hold more share of the overall end-user segment. The home care end-user segment also holds some significant share of the market. Based on geographical segmentation North America, Europe, Asia-Pacific are the growing markets. North America accounts for the large share due to the rising incidence of cardiovascular diseases, and advancement in medical technology. Europe follows North America due to the rising prevalence of the cardiac arrest incidences, and there are rising investments by players operating in the market. 

Semi-automated external defibrillator products hold a large market share in defibrillators market than other defibrillators product segments like automated external defibrillator market. A semi-automated external defibrillator is a portable device that checks the rhythm of the heart and allows the user to send an electric shock to normalize rhythm if not. 

Based on the end-user, the cardioverter defibrillators market is segmented into hospitals, public access markets, home care, and others. The hospitals sub-segment holds the largest share of overall cardioverter defibrillator market. The public access markets segment is expected to grow at the highest CAGR during the forecast period. The main factor that is driving this growth is a rise in the cases of sudden deaths due to cardiac arrest. In the United States alone, more than 350,000 cardiac arrests occur outside the hospital every year and are attended to by the emergency medical services. The other factors driving growth of this segment are the technological advancements in Automated External Defibrillators (AEDs) and also the increase in the number of public defibrillation programs across the globe.

Geographically, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of the cardioverter defibrillator market in this region are the increasing prevalence of cardiac disease in this region and the rising geriatric population. Another major factor driving the growth of cardioverter defibrillators market in Asia-Pacific is the increasing focus of the major players towards this region.

North America dominates the global cardioverter defibrillators market due to the increasing prevalence of cardiovascular diseases in this region. According to the American Heart Association (AHA) approximately 840,678 deaths listed cardiovascular diseases as the underlying cause of death in the year 2016. The association also stated that between 2013 and 2016 approximately 121.5 million Americans had some form of cardiovascular disease. The main factors for the dominance of this region are the rising incidence of cardiovascular diseases, increase in the number of public defibrillation programs in North America, the favourable reimbursement policies, and the technological advancements in cardiac defibrillators.

Geographies covered:

North America

  • US
  • Canada
  • Mexico

Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Rest of APAC

Rest of the World

Latin America

Middle East & Africa

Company Profiles and Competitive Intelligence:

The major players in the Cardioverter Defibrillator market are Medtronic (Ireland), Boston Scientific (US), Abbott (US), Biotronik (Germany), Physio-Control (a part of Stryker) (US), Philips (Netherlands), Cardiac Science (US), Mindray Medical (China), Nihon Kohden Corporation (Japan), and Zoll Medical (US) amongst others.

Medtronic holds a dominant position in the market owing to its broad product portfolio and wider geographic presence. The companies are adopting new product launch and mergers and acquisitions as major strategies in order to gain market share. Companies are also continuously trying to upgrade the existing products by introducing new technologies. For instance, clinical trials are currently underway for Medtronic’s new Extravascular Implantable Cardioverter Defibrillator. The new device does not require leads to be placed inside the veins or heart. Instead the system can deliver shocks and pacing signals to the heart, via a single lead placed under the sternum outside the heart.

Key Questions Answered:

  • What is the value of the overall cardioverter defibrillators market and its segments?
  • What is the market value and volume at the regional and individual country level?
  • What are the attractive segments and geographies to invest in?
  • What are the key drivers, restraints, opportunities, and challenges in the market and how are they expected to impact the market?
  • What are the macroeconomic indicators impacting the country's dynamics?
  • Who are the key market players and their key competitors?
  • Who are the major players present in each region and their key strategies?
  • How are the market players positioned with respect to their business strength and product portfolio?
Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

Table of Content

Chapter 1 Preface

1.1 Report Description

1.1.1 Purpose of the Report

1.1.2 Target Audience

1.1.3 USP and Key Offerings

1.2 Research Scope

1.3 Research Methodology

1.3.1 Phase I – Secondary Research

1.3.2 Phase II – Primary Research

1.3.3 Phase III – Expert Panel Review

1.3.4 Approach Adopted

1.3.4.1 Top-Down Approach

1.3.4.2 Bottom-Up Approach

1.3.5 Assumptions

1.4 Market Segmentation Scope

Chapter 2 Executive Summary

2.1 Market Summary

2.1.1 Global Cardioverter Defibrillators Market, 2016-2023, (Units) (US$ Mn)

2.1 Market Snapshot: Global Cardioverter Defibrillators Market

2.2 Market Dynamics

2.3 Global Cardioverter Defibrillators Market, by Segment, 2018

2.3.1 Global Cardioverter Defibrillators Market, by Product Type, 2018, (Units) (US$ Mn)

2.3.2 Global Cardioverter Defibrillators Market, by End-user, 2018 (Units) (US$ Mn)

2.3.3 Global Cardioverter Defibrillators Market, by Region, 2018 (Units) (US$ Mn)

2.4 Premium Insights

2.4.1 Cardioverter Defibrillators Market In Developed Vs. Developing Economies, 2018 vs 2023

2.4.2 Global Cardioverter Defibrillators Market: Regional Life Cycle Analysis

Chapter 3 Market Dynamics

3.1 Market Overview

3.2 Market Drivers

3.2.1 Increasing Prevalence of Cardiovascular Diseases

3.2.2 Technological Advancements in Defibrillators

3.3 Market Restraints

3.3.1 Issues related to the use of Automated External Defibrillators and Implantable Defibrillators

3.4 Market Opportunities

3.4.1 Increasing Demand from emerging countries

3.5 Industry Value Chain Analysis

3.5.1 Analyst’s Views

3.6 Industry SWOT Analysis

Chapter 4 Global Cardioverter Defibrillators Market, by Product Type

4.1 Market Overview, by Product Type

4.1.1 Global Cardioverter Defibrillators Market, by Product Type, 2016-2023 (Units) (US$ Mn)

4.1.2 Incremental Opportunity, by Product Type, From 2018-2023

4.2 Implantable Cardioverter Defibrillator (ICD)

4.2.1 Global Cardioverter Defibrillators Market, by Implantable Cardioverter Defibrillator (ICD), 2016-2023, (Units) (US$ Mn)

4.2.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

4.2.3 Global Implantable Cardioverter Defibrillators Market, by Subcutaneous Implantable Cardioverter Defibrillator (S-ICD), 2016-2023, (Units) (US$ Mn)

4.2.4 Transvenous Implantable Cardioverter Defibrillator (T-ICD)

4.2.5 Global Implantable Cardioverter Defibrillators Market, by Transvenous Implantable Cardioverter Defibrillator (T-ICD), 2016-2023, (Units) (US$ Mn)

4.2.5.1 Single Chamber Transvenous Implantable Cardioverter Defibrillator

4.2.5.2 Global Transvenous Implantable Cardioverter Defibrillators Market, by Single Chamber Transvenous Implantable Cardioverter Defibrillator, 2016-2023, (Units) (US$ Mn)

4.2.5.3 Dual Chamber Transvenous Implantable Cardioverter Defibrillator

4.2.5.4 Global Transvenous Implantable Cardioverter Defibrillators Market, by Dual Chamber Transvenous Implantable Cardioverter Defibrillator, 2016-2023, (Units) (US$ Mn)

4.2.5.5 Cardiac Resynchronization Therapy Defibrillator (CRT-D)

4.2.5.6 Global Transvenous Implantable Cardioverter Defibrillators Market, by Cardiac Resynchronization Therapy Defibrillator (CRT-D), 2016-2023, (Units) (US$ Mn)

4.3 External Cardioverter Defibrillator

4.3.1 Global Cardioverter Defibrillators Market, by External Cardioverter Defibrillator, 2016-2023, (Units) (US$ Mn)

4.3.2 Automated External Defibrillator (AED)

4.3.3 Global External Cardioverter Defibrillators Market, by Automated External Defibrillator (AED), 2016-2023, (Units) (US$ Mn)

4.3.4 Wearable Cardioverter Defibrillator

4.3.5 Global External Cardioverter Defibrillators Market, by Wearable Cardioverter Defibrillator, 2016-2023, (Units) (US$ Mn)

4.3.6 Manual Cardioverter Defibrillator

4.3.7 Global External Cardioverter Defibrillators Market, by Manual Cardioverter Defibrillator, 2016-2023, (Units) (US$ Mn)

Chapter 5 Global Cardioverter Defibrillators Market, by End-user

5.1 Market Overview, by End-user

5.1.1 Global Cardioverter Defibrillators Market, by End-user, 2016-2023 (Units) (US$ Mn)

5.1.2 Incremental Opportunity, by End-user, From 2018-2023

5.2 Hospitals

5.2.1 Global Cardioverter Defibrillators Market, by Hospitals, 2016-2023, (Units) (US$ Mn)

5.3 Public Access Markets

5.3.1 Global Cardioverter Defibrillators Market, by Public Access Markets, 2016-2023, (Units) (US$ Mn)

5.4 Home Care

5.4.1 Global Cardioverter Defibrillators Market, by Home Care, 2016-2023, (Units) (US$ Mn)

5.5 Others

5.5.1 Global Cardioverter Defibrillators Market, by Others, 2016-2023, (Units) (US$ Mn)

Chapter 6 Global Cardioverter Defibrillators Market, by Region

6.1 Market Overview, by Region

6.1.1 Global Cardioverter Defibrillators Market, by Region, 2016-2023, (Units) (US$ Mn)

6.2 Attractive Investment Opportunity, by Region, 2018

6.3 North America Cardioverter Defibrillators Market

6.3.1 North America Cardioverter Defibrillators Market, by Product Type, 2016-2023 (Units) (US$ Mn)

6.3.2 North America Cardioverter Defibrillators Market, by End-user, 2016-2023 (Units) (US$ Mn)

6.3.3 United States Country Profile

6.3.3.1 United States Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.3.4 Canada Country Profile

6.3.4.1 Canada Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.3.5 Mexico Country Profile

6.3.5.1 Mexico Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.4 Europe Cardioverter Defibrillators Market

6.4.1 Europe Cardioverter Defibrillators Market, by Product Type, 2016-2023 (Units) (US$ Mn)

6.4.2 Europe Cardioverter Defibrillators Market, by End-user, 2016-2023 (Units) (US$ Mn)

6.4.3 United Kingdom Country Profile

6.4.3.1 United Kingdom Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.4.4 Germany Country Profile

6.4.4.1 Germany Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.4.5 France Country Profile

6.4.5.1 France Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.4.6 Italy Country Profile

6.4.6.1 Italy Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.4.7 Spain Country Profile

6.4.7.1 Spain Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.4.8 Rest of Europe

6.4.8.1 Rest of Europe Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.5 Asia Pacific Cardioverter Defibrillators Market

6.5.1 Asia Pacific Cardioverter Defibrillators Market, by Product Type, 2016-2023 (Units) (US$ Mn)

6.5.2 Asia Pacific Cardioverter Defibrillators Market, by End-user, 2016-2023 (Units) (US$ Mn)

6.5.3 China Country Profile

6.5.3.1 China Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.5.4 Japan Country Profile

6.5.4.1 Japan Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.5.5 India Country Profile

6.5.5.1 India Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.5.6 South Korea Country Profile

6.5.6.1 South Korea Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.5.7 Rest of Asia Pacific

6.5.7.1 Rest of Asia Pacific Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.6 Rest of the WorldCardioverter Defibrillators Market

6.6.1 Rest of the World Cardioverter Defibrillators Market, by Product Type, 2016-2023 (Units) (US$ Mn)

6.6.2 Rest of the World Cardioverter Defibrillators Market, by End-user, 2016-2023 (Units) (US$ Mn)

6.6.3 Latin America

6.6.3.1 Latin America Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

6.6.4 Middle East & Africa

6.6.4.1 Middle East & Africa Cardioverter Defibrillators Market, 2016-2023 (Units) (US$ Mn)

Chapter 7 Competitive Intelligence

7.1 Market Players Present in Market Life Cycle

7.2 Top 5 Players Comparison

7.3 Market Positioning of Key Players, 2018

7.4 Market Players Mapping

7.4.1 By Product Type

7.4.2 By Application

7.4.3 By End-user

7.4.4 By Region

7.5 Strategies Adopted by Key Market Players

7.6 Recent Developments in the Market

7.6.1 Mergers & Acquisitions, Partnership, New Product Developments

7.7 Operational Efficiency Comparison by Key Players

Chapter 8 Company Profiles

8.1 Abbott

8.1.1 Abbott Overview

8.1.2 Key Stakeholders/Person in Abbott

8.1.3 Abbott Products Portfolio

8.1.4 Abbott Financial Overview

8.1.5 Abbott News/Recent Developments

8.2 Boston Scientific

8.2.1 Boston Scientific Overview

8.2.2 Key Stakeholders/Person in Boston Scientific

8.2.3 Boston Scientific Products Portfolio

8.2.4 Boston Scientific Financial Overview

8.2.5 Boston Scientific News/Recent Developments

8.3 Biotronik

8.3.1 Biotronik Overview

8.3.2 Key Stakeholders/Person in Biotronik

8.3.3 Biotronik Products Portfolio

8.3.4 Biotronik Financial Overview

8.3.5 Biotronik News/Recent Developments

8.4 Cardiac Science Corporation

8.4.1 Cardiac Science Corporation Overview

8.4.2 Key Stakeholders/Person in Cardiac Science Corporation

8.4.3 Cardiac Science Corporation Products Portfolio

8.4.4 Cardiac Science Corporation Financial Overview

8.4.5 Cardiac Science Corporation News/Recent Developments

8.5 Medtronic

8.5.1 Medtronic Overview

8.5.2 Key Stakeholders/Person in Medtronic

8.5.3 Medtronic Products Portfolio

8.5.4 Medtronic Financial Overview

8.5.5 Medtronic News/Recent Developments

8.6 Mindray Medical

8.6.1 Mindray Medical Overview

8.6.2 Key Stakeholders/Person in Mindray Medical

8.6.3 Mindray Medical Products Portfolio

8.6.4 Mindray Medical Financial Overview

8.6.5 Mindray Medical News/Recent Developments

8.7 Nihon Kohden Corporation

8.7.1 Nihon Kohden Corporation Overview

8.7.2 Key Stakeholders/Person in Nihon Kohden Corporation

8.7.3 Nihon Kohden Corporation Products Portfolio

8.7.4 Nihon Kohden Corporation Financial Overview

8.7.5 Nihon Kohden Corporation News/Recent Developments

8.8 Philips

8.8.1 Philips Overview

8.8.2 Key Stakeholders/Person in Philips

8.8.3 Philips Products Portfolio

8.8.4 Philips Financial Overview

8.8.5 Philips News/Recent Developments

8.9 Physio-Control

8.9.1 Physio-Control Overview

8.9.2 Key Stakeholders/Person in Physio-Control

8.9.3 Physio-Control Products Portfolio

8.9.4 Physio-Control Financial Overview

8.9.5 Physio-Control News/Recent Developments

8.10 Zoll Medical

8.10.1 Zoll Medical Overview

8.10.2 Key Stakeholders/Person in Zoll Medical

8.10.3 Zoll Medical Products Portfolio

8.10.4 Zoll Medical Financial Overview

8.10.5 Zoll Medical News/Recent Developments


Choose License
Buy Now
Why Choose AllTheResearch?
  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on “Quadrant Positioning” of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports. Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.


Quick Inquiry
Follow Us
Choose License
Buy Now